# An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma

> **NCT02473939** · PHASE1 · COMPLETED · sponsor: **Vectura Limited** · enrollment: 85 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** VR942 delivered via a Vectura Dry Powder Inhaler
- **DRUG:** Placebo delivered via a Vectura Dry Powder Inhaler

## Key facts

- **NCT ID:** NCT02473939
- **Lead sponsor:** Vectura Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-04
- **Final completion:** —
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2016-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02473939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02473939, "An Evaluation of VR942 in Healthy Volunteers and Patients With Mild Asthma". Retrieved via AI Analytics 2026-09-27 from https://api.ai-analytics.org/clinical/NCT02473939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*